Hempacco’s master distributors order two truckloads of ‘Dogg lbs’ brand gummies valued at over $1 million

San Diego, California–(Newsfile Corp. – August 31, 2023) – Hempacco Co, Inc. (NASDAQ: HPCO) (“Hempacco”), a hemp smokables company Disrupting Tobacco’s nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced it received purchase orders of $1 million for their highly sought-after product, ‘Dogg lbs’ hemp-derived CBD and Delta-9 infused gummies. These purchase orders are part of the new portfolio of products under the name brand ‘Dogg lbs’ in partnership with Snoop Dogg and are manufactured in San Diego, CA.

The truckloads are going to the deep south and Midwest markets. They are a mix of the two presentations, 20-pack and 5-pack gummies, shipping with point-of-sale displays holding ten gummy pouches per display. The 20-pack gummies sell to the consumer for $29.99, and the 5-pack gummies sell for $9.99. The gummies are made with a custom mold shaped like a small doghouse and come in three flavors: blue raspberry, grape, and lemoncherry.

“We are thrilled to introduce our highly anticipated Snoop Dogg gummy brand, initially launching in two markets,” said Sandro Piancone, CEO of Hempacco. “We already dispatched the first truckload and are diligently preparing the second truckload for shipment.”

Hempacco Receives $1M Purchase Orders for ‘Dogg lbs’ Gummies

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8020/179206_hpco_receives_1m_po_for_dogg_lbs_gummies.jpg

This significant accomplishment demonstrates the growing demand for Hempacco’s innovative products and solidifies their position as a trusted provider in the market. With their commitment to quality and customer satisfaction, it is no surprise that they have secured such a substantial order.

About Hempacco

Hempacco Co., Inc.’s goal is Disrupting Tobacco’s nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff functional hemp cigarette and rolling paper brand.

Hempacco’s operating segments include:

1. Manufacturing of smokables, hemp rolling paper, and cannabinoid sticks
2. Smokable technology development
3. The Real Stuff brand of functional smokables and rolling paper
4. Cheech and Chong Hemp Cigarettes and Hemp Hop Smokables with Rick Ross
5. Snoop Dogg Joint Venture of Hemp-Derived Products

Learn more at www.hempacco.com

For investor inquiries, please contact:

Sandro Piancone, CEO
Investor Relations: ir@hempaccoinc.com
619-779-0715

Safe Harbor Statement

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: (i) potential failure to meet projected development and related targets; (ii) changes in applicable laws or regulations that may impact our products and business; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the “S.E.C.”) by the Company. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Local and national ‘Dogg lbs’ master distributors to attend Snoop Dogg concert hosted by Hempacco’s management team

San Diego, California–(Newsfile Corp. – August 25, 2023) – Hempacco Co, Inc. (NASDAQ: HPCO) (“Hempacco”) plans to host a VIP pre-concert party at Snoop Dogg’s upcoming concert in Irvine, California on Sunday, August 27, 2023. As part of the High School Reunion Tour, Snoop Dogg is touring the US with Wiz Khalifa, Too $hort, and more and plays at the FivePoint Amphitheater. Local and national master distributors who carry the “Dogg lbs” product line will also attend the concert with the Hempacco team.

Hempacco, a hemp smokables company Disrupting Tobacco’s nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, understands the importance of building solid relationships with its salespeople and distributors. To foster this connection, Hempacco extended a special invitation to enjoy an unforgettable experience together. They invited these valued partners to witness the electrifying live performance of legendary artists Snoop Dogg and Wiz Khalifa in Irvine.

This exclusive event will be an opportunity for entertainment and a unique opportunity for Hempacco to showcase the Snoop Dogg line “Dogg lbs” (pronounced “dog pounds”) hemp-derived CBD and Delta-9 infused gummies. Earlier this year, Hempacco partnered with Snoop Dogg to launch a consumer goods company to develop hemp-derived products, including gummies, rolling paper, and blunt tubes, with more categories to be announced.

HPCO Hosts Snoop Dogg Pre-Concert Party

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8020/178567_hpco_hosts_snoop_dogg_pre-concert_party.jpg

“I am so excited to attend the Snoop Dogg and Wiz Khalifa concert alongside some members of my exceptional team,” said Sandro Piancone, CEO of Hempacco. “This is a fun way of bonding with our master distributors from all over the country and show them our new line of Dogg lbs gummies.”

About Hempacco

Hempacco Co., Inc.’s goal is Disrupting Tobacco’s nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff functional hemp cigarette and rolling paper brand.

Hempacco’s operating segments include:

1. Manufacturing of smokables, hemp rolling paper, and cannabinoid sticks
2. Smokable technology development
3. The Real Stuff brand of functional smokables and rolling paper
4. Cheech and Chong Hemp Cigarettes and Hemp Hop Smokables with Rick Ross
5. Snoop Dogg Joint Venture of Hemp-Derived Products

Learn more at www.hempacco.com

For investor inquiries, please contact:

Sandro Piancone, CEO of Hempacco
Investor Relations: ir@hempaccoinc.com
619-779-0715

Forward-Looking and Cautionary Statements

This news release may include forward-looking statements including opinions, assumptions, estimates, the Company’s assessment of future plans and operations, including but not limited to information concerning a potential combination with Hempacco and the timing thereof. When used in this document, the words “will,” “anticipate,” “believe,” “estimate,” “expect,” “intent,” “may,” “project,” “should,” and similar expressions are intended to be among the statements that identify forward-looking statements. The forward-looking statements are founded based on expectations and assumptions made by the Company. Forward-looking statements are subject to a wide range of risks and uncertainties. Although the Company believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will be realized. Any number of important factors could cause actual results to differ materially from those in the forward-looking statements including, but not limited to, regulatory and third-party approvals not being obtained in the manner or timing anticipated; the ability to implement corporate strategies; the state of domestic capital markets; the ability to obtain financing; changes in general market conditions; industry conditions and events; and other factors more fully described from time to time in the reports and filings made by the Company with OTC Markets Group, Inc. or the securities regulatory authorities. Except as required by applicable laws, the Company does not undertake any obligation to publicly update or revise forward-looking statements. We intend that all forward-looking statements be subject to the safe-harbor provisions of relevant securities laws and considered forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

BOULDER, Colo. (March 28, 2023) – A staggering 40 million Americans suffer from anxiety, with only 37% pursuing treatment. Of the 42% of Americans who use cannabis for medicinal purposes, approximately 41% report using it to address anxiety. Now Wana Brands–a leading cannabis-infused products innovator–is on a mission to make cannabis a mainstream wellness tool with its latest release, Wana Optimals Quick Calm Gummies.

Designed to relieve anxious feelings and spiraling thoughts with little to no intoxication, Quick Calm offers a prescription-free alternative wellness solution. Each Quick Calm gummie is powered by two non-intoxicating cannabinoids – 10mg CBD to relieve stress and 10mg CBG to increase levels of the soothing neurotransmitter GABA – plus 1mg of THC to help unlock the full benefits of both. The formulation also contains 30+ stress-relieving terpenes (the chemical compounds that give plants their unique effects) and 50mg L-Theanine, a calming amino acid found in green tea. Quick Calm Gummies harness Azuca’s fast-acting Thermodynamic individual Molecular Encapsulation Technology for a quick 5-15 minute onset. Each package contains 10 gummies.

“Whether we experience it once in a while or every day, we all deal with anxious feelings,” said Nancy Whiteman, CEO of Wana Brands. “Quick Calm uses the latest cannabis science to help give your mind the space to pause, quiet, and refocus.”

Wana Optimals, a suite of daily wellness products powered by rare and major cannabinoids, terpenes, and other plant-based ingredients, serve to help people achieve important health goals such as sound sleep and calm feelings. Earlier Wana Optimals product releases include Fast Asleep, a fast-acting product to induce sleep by addressing discomfort and stress, and Stay Asleep, a longer-lasting option to keep sleeplessness at bay all night long. All Wana products are manufactured in line with cGMP and HACCP practices and are tested for potency.

Wana Optimals Quick Calm gummies are available at Wana Brands partner dispensaries in Colorado, with plans to expand to additional states within the year. For more information on the Wana Optimals line and Quick Calm, visit https://www.wanabrands.com/collections/gummies/optimals/. To find a dispensary offering Wana Brands products near you, visit https://www.wanabrands.com/find/.

For more information or to schedule an interview, contact Emily Meshell at 318-564-8195 or emily@themaverickpr.com.

Wana Brands: Enhance Your Life

With North America’s largest distribution footprint, cannabis edibles producer Wana Brands is a top international brand available in 14 U.S. states, the U.S. territory of Puerto Rico and nine Canadian provinces and territories, generating close to $300 million in retail sales annually across more than 3,000 dispensaries. Through industry-leading innovation, Wana is developing cutting-edge use-case formulations and recipes, such as Wana Quick Fast-Acting Gummies, the top-selling quick-onset edible, and the Optimals Fast Asleep formulation. Wana is committed to the communities it serves by supporting more than 50 charitable organizations in the markets where the company operates. For more information or to subscribe to Wana’s e-newsletter, visit www.wanabrands.com. Follow Wana on LinkedIn, Twitter, YouTube and Pinterest.

Because of the sheer number of options available, it can often be overwhelming for newcomers to shop around and find their perfect gummy. Below, we’ll cover everything you need to know about these infused treats. From why they’re so popular to how to get started, you’ll be able to pick the right option for you.

What’s an Infused Gummy?

Cannabis gummy products combine the delicious, sweet flavors of fruit snacks or candies like gummy worms and bears while providing users with their favorite effects from THC, CBD, and other cannabinoids.

Different types of gummies will bring unique side effects – everything from sleep aids to energy boosters can be found, and as products evolve, the use cases will continue to expand.

Why are Gummies So Popular?

Infused gummies fly off the shelves at most dispensaries, and it’s not hard to see why. Here’s a look at some of the main reasons gummy products have become so popular.

Smoke-Free: Users commonly choose edibles over smoking or vaping marijuana to protect their lung health. While marijuana smoke isn’t necessarily as harmful as cigarettes or cigars, inhaling any type of smoke comes with risks to your health. Edible products provide an alternative for people with breathing conditions or just looking to avoid inhalation.

Easy Dosing: While some trial and error are involved when first starting with edibles, consuming the desired amount couldn’t be easier with gummy products. Most infused gummies come in 100mg packages, with 10 pieces each containing 10mg of THC. Specific products, such as CBD options, might be different, but this is the general standard with THC. It’s essential to read the label of your product to know exactly what the potency is.

Long Shelf Life: This is one of the most significant advantages for casual users. Cannabis gummies will far outlast their baked counterparts like cookies and brownies. They also don’t melt as quickly as chocolate bars, particularly vegan-friendly chewables made with pectin instead of gelatin.

DIY Friendly: While making cannabutter or infused oils has remained popular over the years, many people are just discovering how easy it is to make marijuana gummies at home. With simple ingredients and uncomplicated recipes, you can recreate your favorite infused treat in your kitchen.

How to Start Using Gummies

Using gummies isn’t tricky, but it’s essential to take it slow and allow time for the products to break down and enter your bloodstream before ingesting more. Most edibles can take upwards of two hours to set in, and it’s one of the main reasons people have negative experiences when using these products.

Start by finding an edible that will produce the effects you’re after with cannabis use. Sleep aid gummies are very popular, and they typically contain indica strains and other cannabinoids that will help you sleep. Other products promote energy boosts, likely from sativa strains, and can provide an uplifting boost during the day and increase your focus.

If you prefer indica strains over sativa or vice versa, stick with your favorite when starting with gummies. Because the THC is processed through the liver instead of the brain, the effects often surprise even experienced users.

Start with a small dose, 10-20mg, and give it at least two hours before ingesting more. Users with a high tolerance may require substantially more than this, but it’s best to start slow and have patience. Edibles can sneak up on you, so only take small doses until you become familiar with how they’ll make you feel.

With patience and experimentation, you’ll find an infused gummy product that checks all boxes. Start slow and dose with caution, and you’ll find your perfect high with cannabis gummies.

Transaction Expected to Double Production Capacity and Supports Entry of Direct-to-Consumer Market

SANTA BARBARA, Calif., Oct. 27, 2022 /PRNewswire/ — Bloomios, Inc. (the “Company”) (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, has acquired Infusionz, a wholly-owned subsidiary of Upexi (NASDAQ: UPXI).

“This acquisition is highly accretive and we believe that it will position Bloomios to uplist to Nasdaq,”

Through this transaction, Upexi and Bloomios have forged a long-term partnership. Moving forward, Bloomios will manufacture products retained by Upexi and Upexi has provided significant financing to enable this transaction.

The acquisition includes Infusionz’s portfolio of CBD gummy brands and customers, along with its associated order flow, product formulations, manufacturing operations, equipment and sales team.

The total purchase consideration of approximately $23.5 million consisted of cash consideration of $5.5 million and $18 million of non-cash consideration. The non-cash consideration consisted of the issuance by Bloomios to Upexi of a $4.5 million senior secured convertible debenture, a $5 million secured subordinated promissory note, and shares of a newly created Series D Convertible Preferred Stock with a value of $8.5 million.

The added operations are expected to more than double Bloomios’s current production capacity across key production lines while reducing redundant costs across both the acquired and existing operations. The acquisition will contribute in excess of $22 million in annualized gross revenue.

“This acquisition is highly accretive and we believe that it will position Bloomios to uplist to Nasdaq,” said Barrett Evans, president and chief strategy officer of Bloomios. “Further, it will allow the Company to acquire additional complementary manufacturing operations and brands.”

The new manufacturing operations, large existing customer base, and professional sales team will rapidly expand Bloomios’s gummy manufacturing footprint. Additionally, the Company believes the Infusionz brand will launch the Company’s expansion into the direct-to-consumer market and other new distribution channels.”

“This acquisition enables us to better address unmet demand and significantly improve our operational capabilities,” stated Michael Hill, CEO of Bloomios. “In addition to the new brands and expanded manufacturing capacity, it brings with it a substantial amount of new order flow, positive cash flow, valuable customer relationships, and a highly-capable sales team to drive further growth.”

“We believe this acquisition extends our ability to rapidly create and launch products into today’s booming market for natural, plant-based nutraceutical products,” added Hill. “It should allow Bloomios to tap into the high margin direct-to-consumer market for the first time.”

The acquisition was funded in part through a senior secured convertible debenture offering with an aggregate principal amount of approximately $13,893,059 (including a 15% original issue discount) led by institutional investors. The total new investment received in connection with the senior secured convertible debenture offering was $6.25 million with the balance of the principal amount consisting of issuances to Upexi and the refinancing of previous loans.

The North American market for CBD products is expected to grow at a 33% CAGR to reach $61.3 billion by 2027. The market for alternative cannabinoids is also expanding rapidly at a 20% CAGR and is expected to hit $26.2 billion by 2028.

Bloomios products also target the global CBD skincare market that is anticipated to grow at 24.8% CAGR to $3.4 billion by 2026. This growth is being driven in part by consumers looking for CBD-infused products with natural active ingredients over other chemical-based cosmetics.

As consumers continue to shift toward natural alternatives for improving quality of life, the complementary and alternative medicine market is projected to grow at 22% CAGR to $405 billion by 2028.

To address this opportunity, the Company recently announced it has been engaged by several CBD, nootropic and nutraceuticals brands to develop and produce a new range of private-label consumer health and wellness products. These products will be formulated with natural supplements, including ashwagandha, melatonin, kratom, lion’s mane, valerian root, reishi mushroom, which promote focus, sleep and relaxation, as well as address pain and inflammation. Several of these products are already in the late stages of development and product testing.

Bloomios would like to thank the team at Revere Securities for all of their efforts in completing the transaction.

Additional details regarding the acquisition and related financing will be found in the Company’s Form 8-K to be filed with the Securities and Exchange Commission at www.sec.gov.

About Bloomios
Bloomios, Inc. manufactures, markets and distributes U.S. hemp-derived supplements and nutraceutical products through wholesale distribution channels and its wholly owned subsidiary, Bloomios Private Label. The company provides custom formulation, brand development, manufacturing and order fulfillment to a wide variety of customers, including small and major brands, chain stores, vape shops and distributors. It offers private-label and white-label customers a wide selection of more than 80 customizable hemp products across seven categories. Bloomios is headquartered in Santa Barbara, California, with manufacturing and distribution in Daytona Beach, Florida. To learn more, visit bloomios.com.

Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the sales of the company’s identity protection software products into various channels and market sectors, the issuance of the Company’s pending patent applications, COVID-19, and the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the company.

Company Contact:
Doug Rohrer
Chief Business Officer
Bloomios, Inc.
Tel (805) 222.6467
[email protected]
Customer Inquiries

Investor Relations Contact:
Ronald Both
CMA Investor Relations
Tel (949) 432-7566
Email contact

Media Contact:
Tim Randall
CMA Media Relations
Tel (949) 432-7572
Email Contact

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Rare Cannabinoid Company announced the launch of their latest product: the world’s first hemp THC gummies with high levels of CBC for improved mood and CBD for the entourage effect.

To celebrate, the premium Hawaiian brand is giving away thousands of packets containing 10 THC gummies each, which normally cost $25. Free THC Gummies can be found here.

“We want everyone to experience the blissful relaxation of THC, CBC, and CBD,” said a company spokesperson.

There’s no purchase necessary. Recipients just need to pay shipping and can only receive one free THC gummies packet per address. Or, if they spend just $50, they will get free shipping and a free packet of extra strength THCV gummies for energy and appetite suppression (2 THCV gummies and 2 CBD gummies).

The new Mood Gummies are made with a full spectrum hemp extract chosen for its specific cannabinoid make up. This is because Delta-9-THC and CBC (cannabichromene) were found to offer the most antidepressant-like effects of all cannabinoids, followed by CBD (cannabidiol), in this study.

Each gummy contains 5 mg Delta-9-THC for relaxation and relief from occasional discomfort and nausea. Meanwhile, CBC oil raises levels of a brain molecule called “anandamide,” which is Sanskrit for contentment, happiness, and bliss. CBD oil offers stress relief and promotes the effectiveness of the Delta-9-THC and CBC through the entourage effect.

“Our Mood Gummies are all-natural, vegan, and are flavored with real fresh lime and mint,” said the company spokesperson.

“We believe these are the best THC gummies on the market as, unlike pure THC gummies or CBD gummies with THC, ours contain this special cannabinoid blend with CBC designed to improve one’s mood.”

In addition to the 10-gummy packets, Rare Cannabinoid Company also sells bottles of 30 Delta-9-THC gummies with CBC and CBD for $49.

THC gummies are sold online and in many of the 250 stores that stock Rare Cannabinoid Company products across the United States. You can see the Rare Cannabinoid Company store locator here.

They are legally sold outside cannabis dispensaries because the Delta-9-THC in the gummies comes from federally legal hemp, not cannabis, and is a natural extract. This means that the Delta-9-THC has not been converted or synthesized from CBD or any other cannabinoid. Also, gummies contain less than 0.3% THC by dry weight. However, sales are restricted to adults and THC gummies cannot be shipped internationally.

The new gummies can be taken alone or combined with the Hawaiian brand’s large selection of cannabinoid oils and gummies. These range from THCV, which boosts energy levels and reduces hunger to CBDV which is being studied for autism spectrum disorder and ADHD, and CBN, which promotes rest and sleep. Their full range includes: CBC, CBDA, CBD, CBDV, CBGA, CBG, CBN, THCV, terpene-only tinctures, and broad and full spectrum Hawaiian CBD oils.

All products are produced in a current Good Manufacturing Practices certified facility and have lab test results readily available online and via QR code on product packaging.

Rare Cannabinoid Company recently joined with its sister brand, luxury CBD line, Hawaiian Choice. Both product lines can be found at rarecannabinoidco.com. Brick-and-mortar stores interested in stocking either or both brands can fill out a wholesale application form at Wellness Orders.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

TORONTO, October 04, 2022–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced the upcoming launch of RAD Razzlers, a cannabis gummy that marks the entry into a new product category for Heritage.

Following on the immense popularity of other cannabis products sold across the country under the RAD brand, RAD Razzlers are a new addition to the edibles category and offer unique and popular flavour profiles sought after by cannabis consumers, including Cousin Eddies Eggnog which will be a limited edition flavour offered only during the holidays. RAD Razzlers will initially be offered in packages containing a total of 10 mg of THC, with each gummy containing 2.5 mg of THC.

Manufactured in-house at Heritage, Rad Razzlers will be launching this fall initially with five SKUs in each of Alberta, Saskatchewan, and Manitoba, and three SKUs in Ontario with an additional two SKUs launching in Q1 2023 in the province. Following the official launch, Heritage aims to have RAD Razzlers offered across the country in all provinces as well as bring the edibles portfolio into the U.S.

“While the edibles category in Canada offers many options to consumers, RAD Razzlers taste amazing and are expected to follow on the popularity of our other RAD products which are seeing continued growth in penetration and market share,” said David Schwede, CEO of Heritage. “RAD is an established, successful brand and we see the introduction of RAD Razzlers as a natural progression to extend our product offerings into the edibles category, creating yet another high margin revenue stream for Heritage.”

About Heritage Cannabis Holdings Corp.

Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating under two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the U.S.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“David Schwede”
David Schwede
CEO

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221004005525/en/

Contacts

For more information:
Kelly Castledine
Tel: 647-660-2560

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

– Newest gummies are first in Hemp Bombs’ product line to feature CBN –

TAMPA, Fla., Aug. 26, 2022 /PRNewswire/ — Hemp Bombs®, the manufacturer and distributor of award-winning CBD, Delta-8 THC and Delta-9 THC Gummies, announces its newest additions to its gummy line, Delta-8 Sleep Gummies and Delta-9 Sleep Gummies. These are the first Hemp Bombs gummies to contain the cannabinoid CBN.

“As our experience and reputation shows from manufacturing award-winning, industry-leading CBD, Delta-8 and Delta-9 gummies, innovation is key,” said Vince Gillen, vice president of sales. “Our distribution and retail partners continue to drive our growth across multiple channels with new products that consumers trust and rely on.”

Last year, Hemp Bombs original Delta-8 THC Gummies were named a 2021 Retailer Choice Best New Product by CSP Magazine. Hemp Bombs Delta-8 Sleep Gummies feature 25mg of Delta-8 THC, 5mg of CBN and Hemp Bombs’ proprietary calming blend including chamomile, lemon balm, passionflower and lavender extracts. They come in a Cherry Haze flavor and a 30-count bottle has an MSRP of $38.99.

Hemp Bombs Delta-9 Sleep Gummies contain 10mg of Delta-9 THC, 5mg of CBN and the same proprietary calming blend. They also feature a cherry flavor and are available in 30-count bottles with an MSRP of $44.99.

Customers can also take advantage of new bundles designed to help them save money and enjoy the full selection of Hemp Bombs Delta-8 and Delta-9 gummies. These bundles feature a combination of either a 50-count bottle of Delta-8 or Delta-9 Gummies and a 30-count bottle of Delta-8 or Delta-9 Sleep Gummies with savings up to $22 off the retail price.

Federally compliant under the 2018 Farm Bill, all Hemp Bombs THC Gummies are independently lab tested to ensure safety and compliance with all state and federal regulations.

All Hemp Bombs products are crafted and manufactured by its in-house team of more than 300 employees across four manufacturing and distribution locations in Tampa, Florida.

For more information about its commitment to providing the highest-quality Delta-8 and Delta-9 products and to shop Delta-8 and Delta-9 THC Gummies, visit https://hempbombsplus.com/.

About Us

Hemp Bombs®, founded in 2016 and headquartered in Tampa, Florida, is a manufacturer and distributor of hemp-derived CBD, Delta-8 and Delta-9 cannabinoid products. With more than 150,000 square feet of manufacturing space and over 300 employees, Hemp Bombs manufactures edibles, tinctures, topicals and pet products. Its award-winning gummies and other products are available in more than 20,000 locations nationwide and online at https://hempbombs.com/ and https://hempbombsplus.com/.

Media Contact:
Joe Agostinelli, PR Manager
813-497-5752| [email protected]

SOURCE Hemp Bombs

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

SCOTTSDALE, AZ / ACCESSWIRE / August 18, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is taking an innovative approach by introducing a product that is infused with both Delta-8 & Delta-9.

LBC Bioscience Inc. is yet again dominating the competition by creating new products along with continuous experimenting, and this product is a huge step forward for overall growth of the company! The delicious Green Apple flavored product the company is introducing are Infused Gummies with 15MG of Delta-8 & 10MG of Delta-9 per gummy and will come in a 15-Count Jar. This specific product is ideal for easing the mind while having staying focused all at the same time! All products are carefully blended to ensure consistency along with Third Party Lab Testing for verification. This product will be available in store as of today with the LBC website to follow within the next couple of days.

President & CEO Lisa Nelson states, “We have been working diligently to experiment and create a new product to deliver to our consumers & beloved shareholders and we will continue to keep the public updated moving forward!”

The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson’s, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn’s, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension, even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.

LBC BIOSCIENCE INC. ONLINE STORE

LBC BIOSCIENCE’S Online Emporium

LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings – all at very reasonable prices. Check out LBC Bioscience Inc’s newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.

Become a Distributor

• Large Selection of Products (over 50 items and growing)
• 100% USA Made Products “organic & kosher.”
• All Products are THC-FREE (they contain 0.00% THC)
• Weekly Deals (new deals every week)

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.

Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:

LBC Bioscience Inc’s Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience

About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC’s products can be viewed and purchased on the Company’s website at www.lbcbioscienceinc.com.

Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: [email protected]
Website: www.tenassociatesllc.com

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc’s, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking

SOURCE: CBD Life Sciences Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

As the hemp-derived cannabinoids market continues to evolve, THC-O gummies are the latest trend that’s starting to build up steam with consumers and retailers alike.

What is THC-O and which THC-O gummies are the best options on the market? Find out the answers to these questions and more in our in-depth guide!

What is THC-O?

THC-O, which is known in the scientific community as THC-O-acetate, is an acetic cannabinoid that is created by altering the properties of Cannabidiol (CBD). 

To make THC-O, CBD is first converted into Delta 8 Tetrahydracannabinol (Δ8 THC), which is then combined with a compound known as acetic anhydride. The final compound is THC-O.

What are the Effects of THC-O?

According to Leafly, THC-O is 3 times more potent than Delta 9 THC, which means its effects are also much stronger. The effects of THC-O are said to be more psychedelic in nature, which has led it to be known as a “psychedelic cannabinoid.”

The effects of THC-O can vary depending on a variety of factors, but, in general, users report its effects to be uplifting, alleviating, and almost euphoric.

Top 3 Best THC-O Gummies to Try in 2022

Looking to experiment with this popular, new cannabinoid in a delicious gummy format? Here’s the best 3 THC-O gummies to try in 2022!

1. Galaxy Treats THC-O Gummies

Made in the United States from industrial hemp with the highest-quality ingredients, third-party lab-tested, and highly-rated by consumers and retailers alike, Galaxy Treats offers some of the best THC-O Gummies on the market.

Packed with 25mg of hemp-derived THC-O in each gummy, Galaxy Treats THC-O Moon Babies are available in 2 signature flavors–Citrus Melon and Planetary Peach Berry–and 2 convenient size options–20-Count Jars and 2-Count Packs.

In addition to its popular THC-O Gummies, Galaxy Treats also offers a wide range of other hemp-derived cannabinoid products, including Delta 8 Gummies, HHC Gummies, THC-O Vapes, and HHC Vapes.

Based out of Henderson, Nevada, Galaxy Treats is a top-rated hemp brand that has tons of highly-rated reviews from its loyal customers and offers fast, free shipping on all orders over $30.

Explore Galaxy Treats’ full selection of THC-O gummies here: https://galaxytreats.com/collections/thc-o-edibles

2. Binoid THC-O Gummies

Next on our list is Binoid THC-O Gummies.

Packed with 25mg of THC-O in each gummy, Binoid THC-O Gummies are made in the US, third-party lab-tested and available in a wide variety of flavors including Blueberry Pie, Sour Cherry Lime, and Pine Colada.

To learn more about Binoid, visit their website!

3. Diamond CBD THC-O Gummies

Last on our list is Diamond CBD THC-O Gummies.

Available in 2 signature flavors–Remix and Fruit Smash–Diamond CBD THC-O Gummies contain 25mg each and are available in a large 50-count jar. Like the other brands on our list, all Diamond CBD products are lab-tested, made from industrial hemp and made in the United States.

If you’re looking for a larger size of THC-O gummies, look no further than Diamond CBD!

To learn more about Diamond CBD, visit their website!

THC-O Gummies FAQs

Since THC-O is a relatively new cannabinoid, you probably some questions. Find answers to some of the most commonly asked questions about THC-O below.

Is THC-O Legal?

Hemp-derived THC-O products are federally legal under the 2018 Farm Bill; however, the laws and regulations can vary from state to state. That said, you should always research the laws in your state before purchasing any THC-O products.

How Many THC-O Gummies Should I Take?

Since there are a wide variety of factors involved, including amount of THC-O in the gummy, metabolic rate of the consumer, and experience with cannabinoids, there isn’t a one-size fits all answer to this question. In general, you should start with a lower dosage and move up from there depending on your preferences.

Is THC-O Safe?

When purchasing THC-O products, or any products for that matter, it’s important to only purchase from a trustworthy and reputable source. Since THC-O is more processed than other cannabinoids, it’s strongly not recommended to purchase from a mystery source and to always check the lab reports of the product you are considering. Lastly, it is strongly recommended to start with a minimal dose in order to gauge your body’s reaction to THC-O.

The news and editorial staff of the Bay Area News Group had no role in this post’s preparation.